These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. Interferon-alpha, zidovudine, and granulocyte-macrophage colony-stimulating factor: a phase I AIDS Clinical Trials Group study in patients with Kaposi's sarcoma associated with AIDS. Krown SE; Paredes J; Bundow D; Polsky B; Gold JW; Flomenberg N J Clin Oncol; 1992 Aug; 10(8):1344-51. PubMed ID: 1634925 [TBL] [Abstract][Full Text] [Related]
18. Granulocyte-macrophage colony-stimulating factor and interferon-alpha 2B in patients with advanced renal cell carcinoma. Lümmen G; Sperling H; Luboldt H; Otto T; Rübben H Urol Int; 1998; 61(4):215-9. PubMed ID: 10364752 [TBL] [Abstract][Full Text] [Related]
19. Randomized controlled trial of recombinant human granulocyte-macrophage colony-stimulating factor for the treatment of chronic hepatitis c. Carreño V; Martín J; Pardo M; Brotons A; Anchía P; Navas S; Fernández M; Arocena C; Quiroga JA Cytokine; 2000 Feb; 12(2):165-70. PubMed ID: 10671303 [TBL] [Abstract][Full Text] [Related]
20. World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management. Shomali W; Gotlib J Am J Hematol; 2022 Jan; 97(1):129-148. PubMed ID: 34533850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]